In another study, a formulation containing four Bifidobacterium strains significantly reduced total cholesterol (TC) levels and downregulated interleukin-2 (IL-2) expression—a key pro-inflammatory cytokine—in patients with DKD, indicating potential lipid-lowering and anti-inflammatory benefits. Here, IL2 is linked to diabetic kidney disease.